Clinical Trial Update: A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nivolumab alone or in combination with ipilimumab before surgery to assess safety in bladder cancer patients who are not sui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Bladder Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING